Clinical Trials Logo

Clinical Trial Summary

This is a prospective study designed to evaluate the structural and functional integrity of transcatheter or surgical bioprosthetic valves with multimodality imaging. The study further aims to confirm resolution of the early bioprosthetic valve thrombotic changes with anticoagulation.


Clinical Trial Description

Patients with a history of bioprosthetic valve replacement undergo cardiac contrast CT imaging and transthoracic echocardiography to evaluate structural and functional integrity of the aortic valves. The imaging studies will be performed at least 48-hours after bioprosthetic valve replacement. Patients with prosthetic valve abnormalities suggestive of thrombus will be administered anticoagulation therapy, followed by repeat contrast CT of the chest and transthoracic imaging. Repeat imaging following 3 months of anticoagulation therapy is performed to evaluate the response to anticoagulation therapy. I ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02318342
Study type Interventional
Source Cedars-Sinai Medical Center
Contact Tarun Chakravarty, MD
Phone 3104233977
Email tarunchakravarty@gmail.com
Status Recruiting
Phase N/A
Start date December 2014
Completion date December 2026

See also
  Status Clinical Trial Phase
Completed NCT00232622 - A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots Phase 3
Completed NCT03943966 - In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer N/A
Completed NCT01451320 - Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis N/A